S2: Ep2 The Latest Breakthroughs in Esophageal Cancer скачать в хорошем качестве

S2: Ep2 The Latest Breakthroughs in Esophageal Cancer

Source: https://www.spreaker.com/user/oncolog... Join Maryland Oncology hematology host Ravin Garg, M.D. as he interviews Vincent Lam, M.D. about new breakthroughs, research and therapies in Esophageal Cancer Vincent K. Lam, M.D., an Assistant Professor of Oncology and Director, Esophageal Cancer Research Program at Johns Hopkins, is also clinical/translational investigator with a special interest in lung cancer. Prior to joining the faculty at Johns Hopkins, Dr. Lam was on faculty at MD Anderson Cancer Center and previously completed his hematology/oncology fellowship at the University of Maryland. Dr. Lam’s research includes on-going efforts to develop the clinical utility of liquid biopsies in cancer. He has also led multiple early-phase immunotherapy clinical studies, including T-cell therapy trials in lung cancer. As an investigator with computational bioinformatics expertise, Dr. Lam is interested in applying genomic analytics to better understand why many lung cancers don’t respond to immunotherapy and to develop new immunotherapies for these patients. Your host Ravin Jain Garg, M.D. is a board certified Oncologist and Hematologist who joined Maryland Oncology Hematology at our new Annapolis location in October 2020. Dr Garg attended the University of Michigan—Ann Arbor for his Undergraduate studies. He then attended Medical School at the University of Chicago Pritzker School of Medicine. While there, he was awarded the Humanism in Medicine Award given to the one graduating Medical student who displayed the highest level of kindness and empathy. He then attended the University of Michigan—Ann Arbor for both his Internship and Internal Medicine Residency. Prior to starting his Hematology and Oncology fellowship, he was an Instructor of Medicine at Johns Hopkins where he cared for patients and taught the Medical Residents at Johns Hopkins. He completed his Hematology and Oncology fellowship at The MD Anderson Cancer Center, Houston TX. During his time there, he published several research articles in prestigious medical journals, and he served as the Chief Fellow for Education. Since 2012, he has been an Assistant Professor of Oncology at Johns Hopkins Hospital. He is the founder and writer of all 2300+ questions/answers contained in Hemeoncquestions.com. It is considered the premier Board Review website in the country that has been used by over 9000 Hematologists/Oncologists all over the world.